7,409.50

+7.50

+0.10%

51,501.00

+116.00

+0.23%

27,127.50

+42.25

+0.16%

Russell 2000 Futures

2,766.10

+5.60

+0.20%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,076.30

+1.40

+0.03%

75,136.31

-617.64

-0.82%

Crude Oil Dec 26

90.39

-0.44

-0.48%

US Private Equity

10,772.76

+11.83

+0.11%

NYSE American - Delayed Quote USD

Xtant Medical Holdings, Inc. (XTNT)

0.2894 -0.0106 (-3.53%)

At close: November 6 at 4:00:00 PM EST

Loading Chart for XTNT

Chart Range Bar

Interval:

In partnership with ChartIQ

Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ...

Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ...

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ...

Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ...

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary

Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary

Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Xtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary

Xtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary

Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market

Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market

Mobilize your Website

View Site in Mobile | Classic

Share by: